WallStSmart
SCNI

Scinai Immunotherapeutics Ltd

NASDAQ: SCNI · HEALTHCARE · BIOTECHNOLOGY

$0.74
+3.67% today

Updated 2026-04-30

Market cap
$2.06M
P/E ratio
0.00
P/S ratio
1.58x
EPS (TTM)
$0.00
Dividend yield
52W range
$0 – $3
Volume
4.1M

Scinai Immunotherapeutics Ltd (SCNI) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20052006200720092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$10000.00$-852947.00$-2.29M$-2.71M$-1.82M$-1.21M$-1.94M$-2.63M$-2.51M$-2.89M$-15.29M$-22.31M$-22.57M$-7.43M$-7.26M$-9.38M$-6.33M$-6.03M
Capital expenditures$10000.00$0.00$4000.00$31322.00$301937.00$764006.00$80389.00$56523.00$7699.00$8725.00$5191.00$1.30M$6.35M$2.15M$1.91M$133122.00$836000.00$637000.00$12000.00$24000.00
Depreciation
Stock-based comp$560000.00$516000.00$162360.00$93165.00$191197.00$327294.00$149155.00$69526.00$1.07M$2.95M$2.76M$1.60M$1.14M$682000.00$303000.00
Free cash flow$10000.00$-884269.00$-2.59M$-3.47M$-1.90M$-1.27M$-1.95M$-2.64M$-2.51M$-4.18M$-21.64M$-24.47M$-24.48M$-7.56M$-8.10M$-10.02M$-6.35M$-6.05M
Investing cash flow
Financing cash flow
Dividends paid
Share repurchases
Debt repayment
Net change in cash